Preferred reporting items for a systematic review and meta-analysis of individual participant data: The PRISMA-IPD statement

JAMA - Journal of the American Medical Association

Volumn 313, Issue 16, 2015, Pages 1657-1665

  Stewart, Lesley A ^a   Clarke, Mike ^b   Rovers, Maroeska ^c   Riley, Richard D ^d,e   Simmonds, Mark ^a   Stewart, Gavin ^a,f   Tierney, Jayne F ^g  

^a UNIVERSITY OF YORK   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d KEELE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKLIST; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; DIAGNOSIS; EDITOR; GOLD STANDARD; HUMAN; INDIVIDUAL PARTICIPANT DATA; INFORMATION; INFORMATION PROCESSING; META ANALYSIS (TOPIC); METHODOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH; REVIEW; SCIENTIST; SYSTEMATIC REVIEW (TOPIC); WORKSHOP; LITERATURE; PUBLISHING; RANDOMIZATION; RESEARCH SUBJECT; STANDARDS; STATISTICAL ANALYSIS;

CHECKLIST; DATA INTERPRETATION, STATISTICAL; GUIDELINES AS TOPIC; META-ANALYSIS AS TOPIC; PUBLISHING; RANDOM ALLOCATION; RESEARCH SUBJECTS; REVIEW LITERATURE AS TOPIC;

EID: 84928753669     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.3656     Document Type: Review

References (35)

1. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 2009;6(7):e1000097.
2. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7(2):e1000217.
3. Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials. 2005;2(3):209-217.
4. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.
5. Chalmers I; Cochrane Collaboration. The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Ann N Y Acad Sci. 1993;703:156-163.
6. Stewart LA, Clarke MJ; Cochrane Working Group. Practical methodology ofmeta-analyses (overviews) using updated individual patient data. Stat Med. 1995;14(19):2057-2079.
7. Stewart LA, Tierney JF. To IPD or not to IPD? advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof. 2002;25(1):76-97.
8. Stewart L, Tierney J, Burdett S. Do systematic reviews based on individual patient data offer a means of circumventing biases associated with trial publications? In: Rothstein H, Sutton A, Borenstein M, eds. Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments. Chichester, United Kingdom: John Wiley & Sons; 2005:261-286.
9. Burgess S, White IR, Resche-Rigon M, Wood AM. Combining multiple imputation and meta-analysis with individual participant data. Stat Med. 2013;32 (26):4499-4514.
10. Debray TP, Moons KG, Ahmed I, Koffijberg H, Riley RD. A framework for developing, implementing, and evaluating clinical prediction models in an individual patient data meta-analysis. Stat Med. 2013;32(18):3158-3180.
11. Phillips RS, Sutton AJ, Riley RD, Chisholm JC, Picton SV, Stewart LA; PICNICC Collaboration. Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol). Syst Rev. 2012;1:8.
12. Clarke M, Stewart L, Pignon JP, Bijnens L. Individual patient data meta-analysis in cancer. Br J Cancer. 1998;77(11):2036-2044.
13. Selker HP, Griffith JL, Beshansky JR, et al. Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med. 1997;127(7):538-556.
14. Krumholz HM. Why data sharing should be the expected norm. BMJ. 2015;350:h599.
15. Lo B. Sharing clinical trial data: maximizing benefits,minimizing risk. JAMA. 2015;313(8):793-794.
16. Ahmed I, Sutton AJ, Riley RD. Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey. BMJ. 2012;344:d7762.
17. Beller EM, Glasziou PP, Altman DG, et al PRISMA for Abstracts Group. PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Med. 2013;10(4): e1001419.
18. Vale CL, Rydzewska LHM, Rovers MM, Emberson JR, Gueyffier F, Stewart LA; Cochrane IPD Meta-analysis Methods Group. Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study. BMJ. 2015;350:h1088.
19. Schmid CH, Landa M, Jafar TH, et al Angiotensin-Converting Enzyme Inhibition in Progressive Renal Disease (AIPRD) Study Group. Constructing a database of individual clinical trials for longitudinal analysis. Control Clin Trials. 2003;24 (3):324-340.
20. Riley RD, Lambert PC, Staessen JA, et al. Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med. 2008;27(11):1870-1893.
21. Abo-Zaid G, Guo B, Deeks JJ, et al. Individual participant data meta-analyses should not ignore clustering. J Clin Epidemiol. 2013;66(8):865-873.
22. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ. 1995;311(7010):899-909.
23. Steyerberg EW, Moons KG, van der Windt DA, et al PROGRESS Group. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10(2):e1001381.
24. Hingorani AD, Windt DA, Riley RD, et al PROGRESS Group. Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ. 2013;346:e5793.
25. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women. N Engl J Med. 1988;319(26):1681-1692.
26. Advanced Ovarian Cancer Trialists' Group. Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. BMJ. 1991; 303(6807):884-893.
27. Mant J, Doust J, Roalfe A, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess. 2009;13(32):1-207.
28. Abo-Zaid G, Sauerbrei W, Riley RD. Individual participant data meta-analysis of prognostic factor studies: state of the art? BMC Med Res Methodol. 2012;12:56.
29. Ahmed I, Debray TP, Moons KG, Riley RD. Developing and validating risk prediction models in an individual participant data meta-analysis. BMC Med Res Methodol. 2014;14:3.
30. Danesh J, Lewington S, Thompson SG, et al Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005;294(14): 1799-1809.
31. van der A DL, Rovers MM, Grobbee DE, et al. Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjects. Circ Cardiovasc Genet. 2008;1(1):43-50.
32. Burgess S, Thompson SG; Genetics Collaboration CC. Methods for meta-analysis of individual participant data from mendelian randomisation studies with binary outcomes [published online June 19, 2012]. Stat Methods Med Res. doi:10.1177/0962280212451882.
33. Bath PM, Gray LJ, Bath AJ, Buchan A, Miyata T, Green AR; NXY-059 Efficacy Meta-analysis in Individual Animals With Stroke Investigators. Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. Br J Pharmacol. 2009;157(7):1157-1171.
34. Schmidt AF, Nielen M, Klungel OH, et al; V.S.S.O. Investigators. Prognostic factors of early metastasis and mortality in dogs with appendicular osteosarcoma after receiving surgery: an individual patient data meta-analysis. Prev Vet Med. 2013;112 (3-4):414-422.
35. Berlin JA, Ghersi D. Preventing publication bias: registries and prospective meta-analysis. In: Rothstein HR, Sutton AJ, Borenstein M, eds. Publication Bias in Meta-analysis: Prevention, Assessment and Adjustments. Chichester, United Kingdom: John Wiley & Sons; 2005:35-48.